Safety, Tolerability and Pharmacokinetics of ETD-001 Gel
NCT07674862
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Safety Issues
Interventions
DRUG:
Dose 1
DRUG:
dose 2
DRUG:
dose 3
Sponsor
Etern Therapeutics Wuxi Limited